Profile data is unavailable for this security.
About the company
Immunotech Biopharm Ltd is an investment holding company primarily engaged in the research and development, manufacturing and commercialisation of immune cell products for treatments of cancers. The Company's non-genetically modified cell product pipeline includes Expanded Activated Lymphocytes (EAL) and 6B11-OCIK Injection. The Company's chimeric antigen receptor T (CAR-T) cell product pipeline includes CAR-T-19 Injection, Denocabtagene Ciloleucel Injection and aT19 Injection. The Company's T cell receptor engineered T cell therapy (TCR-T) cell product pipeline includes YT003, YT008 and YT007. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-252.80m
- Incorporated2018
- Employees173.00
- LocationImmunotech Biopharm Ltd8th Floor, Building 1Guosheng Science and Technology ParkNo.1 Kangding Street, Economic and TechnBeijing ChinaCHN
- Websitehttps://www.eaal.net/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JW (Cayman) Therapeutics Co Ltd | 201.05m | -698.60m | 770.48m | 292.00 | -- | 0.7493 | -- | 3.83 | -1.68 | -1.68 | 0.4846 | 2.47 | 0.1046 | 1.34 | 9.59 | 715,492.90 | -36.34 | -35.14 | -47.41 | -39.06 | 55.52 | -- | -347.47 | -898.77 | 1.45 | -1,808.42 | 0.2907 | -- | -8.99 | -- | 23.10 | -- | -32.98 | -- |
| Brii Biosciences Ltd | 0.00 | -424.95m | 988.50m | 96.00 | -- | 0.3505 | -- | -- | -0.5838 | -0.5838 | 0.00 | 3.91 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| Sunho Biologics Inc | 0.00 | -92.85m | 1.00bn | 128.00 | -- | 1.84 | -- | -- | -0.6152 | -0.6152 | 0.00 | 3.47 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| B&K Corp Ltd | 295.22k | -206.56m | 1.04bn | 100.00 | -- | 10.85 | -- | 3,515.15 | -1.76 | -1.76 | 0.0025 | 0.8127 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -329.33m | 1.09bn | 57.00 | -- | 2.74 | -- | -- | -0.7284 | -0.7284 | 0.00 | 0.6933 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | 164.01m | -88.27m | 1.10bn | 106.00 | -- | -- | -- | 6.74 | -0.4553 | -0.4553 | 0.8461 | -0.1601 | 0.5805 | 11.54 | 13.96 | 1,451,423.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| Kintor Pharmaceutical Ltd | 12.42m | -188.97m | 1.27bn | 136.00 | -- | 4.67 | -- | 102.35 | -0.4369 | -0.4369 | 0.0287 | 0.546 | 0.0194 | 10.66 | 1.06 | 73,952.98 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Immunotech Biopharm Ltd | 0.00 | -252.80m | 1.45bn | 173.00 | -- | -- | -- | -- | -0.4517 | -0.4517 | 0.00 | -0.2878 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.80m | -342.37m | 1.50bn | 195.00 | -- | 2.34 | -- | 11.81 | -0.8703 | -0.8703 | 0.322 | 1.48 | 0.148 | -- | 3,865.48 | 812,796.10 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 479.51m | -31.08m | 1.65bn | 383.00 | -- | 14.75 | 44.74 | 3.44 | -0.0075 | -0.0075 | 0.1163 | 0.0271 | 0.4209 | 0.4659 | 4.05 | 1,522,250.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Cloudbreak Pharma Inc | 78.04m | -326.47m | 1.67bn | 60.00 | -- | -- | -- | 21.46 | -0.3892 | -0.3892 | 0.093 | -3.07 | -- | -- | -- | 1,530,235.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 12.33m | -739.64m | 2.08bn | 507.00 | -- | 10.14 | -- | 168.46 | -1.55 | -1.55 | 0.0258 | 0.4242 | 0.006 | -- | -- | 23,216.49 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Antengene Corp Ltd | 95.41m | -258.57m | 2.15bn | 152.00 | -- | 2.48 | -- | 22.50 | -0.4161 | -0.4161 | 0.1536 | 1.28 | 0.0619 | 1.51 | 3.20 | 564,570.70 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
Data as of Mar 05 2026. Currency figures normalised to Immunotech Biopharm Ltd's reporting currency: Hong Kong Dollar HKD
0.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 06 Feb 2026 | 268.00k | 0.04% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
